Bookmark

Add to MyYahoo RSS

Fibrosis News

News on Fibrosis continually updated from thousands of sources around the net.

Thursday | Benzinga

Galectin Therapeutics Announces First Patient Dosed in Second Cohort...

Galectin Therapeutics , the leading developer of therapeutics that target galectin proteins to treat fibrosis and cancer, announced today that the first patient in cohort 2 of its Phase 1 clinical trial of GR-MD-02 in patients with NASH with advanced fibrosis has been successfully dosed with 4 mg/kg, which is double the dose given in cohort 1.

Comment?

Related Topix: Medicine, Health, Healthcare Law, Law, Food and Drug Administration

Thursday | Medical News

Alcresta signs agreement with CFFT to support nutritional status of people with cystic fibrosis

Alcresta, a leading medical nutrition company developing innovative enzyme-based products for individuals with unique nutritional needs battling acute conditions or chronic diseases, today announced the company has signed an agreement with Cystic Fibrosis Foundation Therapeutics to accelerate the development of Alcresta's enzyme-based point-of-care ... (more)

Comment?

Related Topix: Medicine, Cystic Fibrosis, Health, Nutrition, Life, Food, Non-Profit

Thu Apr 10, 2014

TheDay.Com

Cystic Fibrosis Foundation to host fundraising walks

The Connecticut Chapter of the Cystic Fibrosis Foundation will host 11 Great Strides walks around Connecticut in May, including a May 4 walk at Ocean Beach Park in New London.

Comment?

Related Topix: Medicine, Cystic Fibrosis, Health, Charitable Organizations, Cystic Fibrosis Foundation, New London, CT

FremontUniverse

It's Time for the Fremont Troll Stroll

Of course Trolls stroll! And so should you! The 13th Annual Troll Stroll takes place this Saturday April 12th from 1:00-5:00PM throughout the Fremont Neighborhood.

Comment?

Related Topix: Cystic Fibrosis, Health, Charitable Organizations, Cystic Fibrosis Foundation

Mon Apr 07, 2014

BioSpace

Xenetic Biosciences Announces Positive Phase 1 Clinical Data For...

Xenetic Biosciences, Inc. , a biopharmaceutical company focused on developing next-generation biologic drugs and novel oncology therapeutics, today announced the positive results from its Phase I clinical trial of PulmoXenTM for the treatment of cystic fibrosis.

Comment?

Related Topix: Oncology, Medicine, Cystic Fibrosis, Health

Sun Apr 06, 2014

Patch.com

Scoff 2nd Graders 'Pay It Forward' for Cystic Fibrosis Research

Submitted by Valley View School District: Representatives of the Cystic Fibrosis Foundation dropped by Beverly Skoff Elementary School in Romeoville Thursday afternoon to thank Angela Parent's 2nd graders for raising money to help further research into the chronic disease that affects the lungs and digestive system of children and adults.

Comment?

Related Topix: Medicine, Cystic Fibrosis, Health, Education Etc., Romeoville, IL

Fri Apr 04, 2014

Alabama Live

Katie's Kids cystic fibrosis fundraiser expanding to daylong music festival in Gardendale

Jeanne Von Hagel and Thom Duran at the 2010 Swinging for Katie's Kids golf tournament.

Comment?

Related Topix: Medicine, Cystic Fibrosis, Health, Gardendale, AL, Social Software, Knights of Columbus, Insurance

Thu Apr 03, 2014

Canada.com

Provinces want U.S. pharma company to finalize price for cystic fibrosis drug

Provincial governments are banding together to pressure a pharmaceutical manufacturer to finalize a price for a drug that treats a rare form of cystic fibrosis.

Comment?

Related Topix: Medicine, Cystic Fibrosis, Health, Vertex, Biotech, Vertex Pharmaceuticals, Healthcare Industry

Wed Apr 02, 2014

The Jersey Journal

Vineland Y makes healthy kids; Energy assistance; Cystic fibrosis; BEN Column, April 2, update 3

An all-you-can-eat spaghetti dinner to benefit the Cystic Fibrosis Foundation and the Ocean City Great Strides Walk will be held at the Seabrook Fire Hall on Sunday, April 6, from 2 to 6 p.m. Gateway Community Action Partnership announces that the deadline to apply for Low Income Home Energy Assistance will be April 30 and deadline to apply for ... (more)

Comment?

Related Topix: Medicine, Cystic Fibrosis, Health, Events, Bridgeton, NJ

Tue Apr 01, 2014

BioSpace

First Cohort Results In Galectin Therapeutics' Phase 1 Trial Reveal...

Galectin Therapeutics , the leading developer of therapeutics that target galectin proteins to treat fibrosis and cancer, today announced that results from the first cohort of its Phase 1 trial show that GR-MD-02 had an effect on biomarkers that suggest a therapeutic effect on fibrosis, inflammation, and cellular injury.

Comment?

Related Topix: Medicine, Health

Tue Mar 25, 2014

Examiner.com

The Annapolis Design District 'Paints the Town Blue' for Cystic Fibrosis

For a second year in a row, the Annapolis Design District will be holding their "Paint the Town Blue for Cystic Fibrosis " fundraiser.

Comment?

Related Topix: Medicine, Cystic Fibrosis, Health, Annapolis, MD

The Jersey Journal

Cystic fibrosis; Levoy Theatre; Trash gone; BEN Column, March 25, first update

The column that says let's build Route 60 from the Delaware Memorial Bridge to the shore, with tolls in Salem and Cumberland counties, so we can get the tourist dollars one way or another, as the construction puts people back to work.

Comment?

Related Topix: Medicine, Cystic Fibrosis, Health, Salem County, NJ, Cumberland County, NJ, Theater, Arts

Mon Mar 24, 2014

BioSpace

Galectin Therapeutics Reports 2013 Financial Results

Galectin Therapeutics Inc. , the leading developer of therapeutics that target galectin proteins to treat fibrosis and cancer, today reported its financial results for the year ended December 31, 2013.

Comment?

Related Topix: Medicine, Health, Corporate / Securities Law, Law

The Jersey Journal

Cystic fibrosis research benefits from Zampella School fundraiser

Community members came together to raise more than $5,000 in the the Coins For a Cure For Cystic Fibrosis fundraiser at the Alfred E. Zampella School in Jersey City.

Comment?

Related Topix: Medicine, Cystic Fibrosis, Health, Jersey City, NJ, Rochelle Park, NJ, Genetics

Fri Mar 21, 2014

GlobeNewswire

Galectin Therapeutics Reports 2013 Financial Results

Galectin Therapeutics Inc. , the leading developer of therapeutics that target galectin proteins to treat fibrosis and cancer, today reported its financial results for the year ended December 31, 2013.

Comment?

Related Topix: Health, Corporate / Securities Law, Law, Healthcare Law, Food and Drug Administration

•••
•••
•••
•••
•••
•••
•••
•••
•••